Table of Contents

• Jitender Nagpal and
• Abhishek Bhartia

Quality of Diabetes Care in the Middle- and High-Income Group Populace: The Delhi Diabetes Community (DEDICOM) survey

• Wanda K. Nicholson,
• Keiko Asao,
• Frederick Brancati,
• Josef Coresh,
• James S. Pankow,
• and Neil R. Powe

Parity and Risk of Type 2 Diabetes: The Atherosclerosis Risk in Communities study

• Jamie R. Wood,
• Elaine C. Moreland,
• Lisa K. Volkening,
• Britta M. Svoren,
• Deborah A. Butler,
• and Lori M.B. Laffel

Durability of Insulin Pump Use in Pediatric Patients With Type 1 Diabetes

• Cynthia R. Ong,
• Lynda M. Molyneaux,
• Maria I. Constantino,
• Stephen M. Twigg,
• and Dennis K. Yue

Long-Term Efficacy of Metformin Therapy in Nonobese Individuals With Type 2 Diabetes

• Dan Ziegler,
• Alexander Ametov,
• Alexey Barinov,
• Peter J. Dyck,
• Irina Gurieva,
• Phillip A. Low,
• Ullrich Munzel,
• Nikolai Yakhno,
• Itamar Raz,
• Maria Novosadova,
• Joachim Maus,
• and Rustem Samigullin

Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy: The SYDNEY 2 trial

• Curtis Triplitt,
• Leonard Glass,
• Yoshiniro Miyazaki,
• Estela Wajcberg,
• Amalia Gastaldelli,
• Elena De Filippis,
• Eugenio Cersosimo,
• and Ralph A. DeFronzo

Comparison of Glargine Insulin Versus Rosiglitazone Addition in Poorly Controlled Type 2 Diabetic Patients on Metformin Plus Sulfonylurea

• H. Andrew W. Neil,
• David A. DeMicco,
• Don Luo,
• D. John Betteridge,
• Helen M. Colhoun,
• Paul N. Durrington,
• Shona J. Livingstone,
• John H. Fuller,
• and Graham A. Hitman

Analysis of Efficacy and Safety in Patients Aged 65–75 Years at Randomization: Collaborative Atorvastatin Diabetes Study (CARDS)

• Besa Smith,
• Deborah L. Wingard,
• Tyler C. Smith,
• Donna Kritz-Silverstein,
• and Elizabeth Barrett-Connor

Does Coffee Consumption Reduce the Risk of Type 2 Diabetes in Individuals With Impaired Glucose?

• Piya Ballani,
• Michael T. Tran,
• Maria D. Navar,
• and Mayer B. Davidson

Clinical Experience With U-500 Regular Insulin in Obese, Markedly Insulin-Resistant Type 2 Diabetic Patients

• Diana Rucker,
• Jeffrey A. Johnson,
• T.K. Lee,
• Dean T. Eurich,
• Richard Z. Lewanczuk,
• Scot H. Simpson,
• Ellen L. Toth,
• and Sumit R. Majumdar

The Natural History of LDL Control in Type 2 Diabetes: A prospective study of adherence to lipid guidelines

• Terri H. Lipman,
• Abbas F. Jawad,
• Kathryn M. Murphy,
• Alan Tuttle,
• Rebecca L. Thompson,
• Sarah J. Ratcliffe,
• and Lorraine E. Levitt Katz

Incidence of Type 1 Diabetes in Philadelphia Is Higher in Black Than White Children From 1995 to 1999: Epidemic or misclassification?

• Chaoyang Li,
• Earl S. Ford,
• Lisa C. McGuire,
• Ali H. Mokdad,
• Randie R. Little,
• and Gerald M. Reaven

Trends in Hyperinsulinemia Among Nondiabetic Adults in the U.S.

• Jeffrey A. Johnson,
• Sheri L. Pohar,
• and Sumit R. Majumdar

Health Care Use and Costs in the Decade After Identification of Type 1 and Type 2 Diabetes: A population-based study

• Hua-Fen Chen,
• Ching-An Ho,
• and Chung-Yi Li

Age and Sex May Significantly Interact With Diabetes on the Risks of Lower-Extremity Amputation and Peripheral Revascularization Procedures: Evidence from a cohort of a half-million diabetic patients

• Elizabeth Selvin,
• Josef Coresh,
• and Frederick L. Brancati

The Burden and Treatment of Diabetes in Elderly Individuals in the U.S.

• Carlos A. Aguilar-Salinas,
• Rosalba Rojas,
• Clicerio Gonzalez-Villalpando,
• Francisco J. Gómez-Pérez,
• Roopa Mehta,
• Gustavo Olaiz,
• Juan A. Rull,
• and David R. Cox

Design and Validation of a Population-Based Definition of the Metabolic Syndrome

• Joyce M. Lee,
• Megumi J. Okumura,
• Matthew M. Davis,
• William H. Herman,
• and James G. Gurney

Prevalence and Determinants of Insulin Resistance Among U.S. Adolescents: A population-based study

• Boris P. Kovatchev,
• Erik Otto,
• Daniel Cox,
• Linda Gonder-Frederick,
• and William Clarke

Evaluation of a New Measure of Blood Glucose Variability in Diabetes

• Peter C.Y. Tong,
• Alice P.S. Kong,
• Wing-Yee So,
• Margaret H.L. Ng,
• Xilin Yang,
• Maggie C.Y. Ng,
• Ronald C.W. Ma,
• Chung-Shun Ho,
• Christopher W.K. Lam,
• Chun-Chung Chow,
• Clive S. Cockram,
• and Juliana C.N. Chan

Hematocrit, Independent of Chronic Kidney Disease, Predicts Adverse Cardiovascular Outcomes in Chinese Patients With Type 2 Diabetes

• Yoshimitsu Yamasaki,
• Naoto Katakami,
• Ken’ya Sakamoto,
• Hideaki Kaneto,
• Munehide Matsuhisa,
• Hiroshi Sato,
• Masatsugu Hori,
• Masakazu Haneda,
• Atsunori Kashiwagi,
• Yasushi Tanaka,
• Ryuzo Kawamori,
• and Shin-ichi Kuno

Combination of Multiple Genetic Risk Factors Is Synergistically Associated With Carotid Atherosclerosis in Japanese Subjects With Type 2 Diabetes

• Dorte Hansen,
• Bendt Brock-Jacobsen,
• Elisabeth Lund,
• Christina Bjørn,
• Lars P. Hansen,
• Christian Nielsen,
• Claus Fenger,
• Søren T. Lillevang,
• and Steffen Husby

Clinical Benefit of a Gluten-Free Diet in Type 1 Diabetic Children With Screening-Detected Celiac Disease: A population-based screening study with 2 years’ follow-up

• Young Min Cho,
• Byung-Soo Youn,
• Hyewon Lee,
• Namseok Lee,
• Sung-Shik Min,
• Soo Heon Kwak,
• Hong Kyu Lee,
• and Kyong Soo Park

Plasma Retinol-Binding Protein-4 Concentrations Are Elevated in Human Subjects With Impaired Glucose Tolerance and Type 2 Diabetes

• Rafael Simó,
• Albert Lecube,
• Joan Genescà,
• Joan Ignaci Esteban,
• and Cristina Hernández

Sustained Virological Response Correlates With Reduction in the Incidence of Glucose Abnormalities in Patients With Chronic Hepatitis C Virus Infection

• Salvatore De Cosmo,
• Olga Lamacchia,
• Anna Rauseo,
• Raffaella Viti,
• Loreto Gesualdo,
• Alessandra Pilotti,
• Vincenzo Trischitta,
• and Mauro Cignarelli

Cigarette Smoking Is Associated With Low Glomerular Filtration Rate in Male Patients With Type 2 Diabetes

• Monica Nannipieri,
• Rosalinda Posadas,
• Alessandra Bonotti,
• Ken Williams,
• Clicerio Gonzalez-Villalpando,
• Michael P. Stern,
• and Ele Ferrannini

Polymorphism of the 3′-Untranslated Region of the Leptin Receptor Gene, but Not the Adiponectin SNP45 Polymorphism, Predicts Type 2 Diabetes: A population-based study

• Makoto Kameyama,
• Osamu Funae,
• Shu Meguro,
• and Yoshihito Atsumi

HbA_1c Values Determine the Outcome of Intrasheath Injection of Triamcinolone for Diabetic Flexor Tenosynovitis

• Giovanni Ravaglia,
• Paola Forti,
• Fabiola Maioli,
• Luciana Bastagli,
• Martina Chiappelli,
• Fausta Montesi,
• Luigi Bolondi,
• and Christopher Patterson

Metabolic Syndrome: Prevalence and prediction of mortality in elderly individuals

• Jonas Lidfeldt,
• Göran Samsioe,
• and Carl-David Agardh

Obese Women and the Relation Between Cardiovascular Risk Profile and Hormone Therapy, Glucose Tolerance, and Psychosocial Conditions

• Jonas F. Ludvigsson,
• Johnny Ludvigsson,
• Anders Ekbom,
• and Scott M. Montgomery

Celiac Disease and Risk of Subsequent Type 1 Diabetes: A general population cohort study of children and adolescents

• Anke Tönjes,
• Markus Scholz,
• Markus Loeffler,
• and Michael Stumvoll

Association of Pro12Ala Polymorphism in Peroxisome Proliferator–Activated Receptor γ With Pre-Diabetic Phenotypes: Meta-analysis of 57 studies on nondiabetic individuals

• Marieke B. Snijder,
• Robert J. Heine,
• Jacob C. Seidell,
• Lex M. Bouter,
• Coen D.A. Stehouwer,
• Giel Nijpels,
• Tohru Funahashi,
• Yuji Matsuzawa,
• Iichiro Shimomura,
• and Jacqueline M. Dekker

Associations of Adiponectin Levels With Incident Impaired Glucose Metabolism and Type 2 Diabetes in Older Men and Women: The Hoorn Study

• Matteo Monami,
• Lorella Lambertucci,
• Andrea Ungar,
• Maria Pieri,
• Giulio Masotti,
• Niccolò Marchionni,
• and Edoardo Mannucci

Is the Third Component of Metabolic Syndrome Really Predictive of Outcomes in Type 2 Diabetic Patients?

• Neil J. Snowling and
• Will G. Hopkins

Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients: A meta-analysis

• Trevor J. Orchard,
• Tina Costacou,
• Adam Kretowski,
• and Richard W. Nesto

Type 1 Diabetes and Coronary Artery Disease

• Barbera van Harten,
• Frank-Erik de Leeuw,
• Henry C. Weinstein,
• Philip Scheltens,
• and Geert Jan Biessels

Brain Imaging in Patients With Diabetes: A systematic review

• Zachary T. Bloomgarden

Glycemic Treatment in Type 1 and Type 2 Diabetes

• Oliver J. Gibson,
• Patrick E. McSharry,
• and Lionel Tarassenko

On the Weighted-Average Relationship Between Plasma Glucose and HbA_1c

• José I. Botella-Carretero,
• Manuel Luque-Ramírez,
• Francisco Álvarez-Blasco,
• José L. San Millán,
• and Héctor F. Escobar-Morreale

Mutations in the Hereditary Hemochromatosis Gene Are Not Associated With the Increased Body Iron Stores Observed in Overweight and Obese Women With Polycystic Ovary Syndrome

• Natalia Hillman,
• Lucrecia Herranz,
• Pilar M. Vaquero,
• Africa Villarroel,
• Alberto Fernandez,
• and Luis F. Pallardo

Is Pregnancy Outcome Worse in Type 2 Than in Type 1 Diabetic Women?

• Umberto Vespasiani Gentilucci,
• Antonio Picardi,
• and Paolo Pozzilli

Glucose Abnormalities in Patients With Hepatitis C Virus Infection: Epidemiology and Pathogenesis: Response to Lecube et al.

• Rafael Simó

Glucose Abnormalities in Patients With Hepatitis C Virus Infection: Epidemiology and Pathogenesis: Response to Gentilucci et al.

• Spiros Fourlanos,
• Leonard C. Harrison,
• and Peter G. Colman

A Clinical Screening Tool Identifies Autoimmune Diabetes in Adults: Response to Davis et al.

• Timothy M.E. Davis,
• Carole A. Cull,
• and Rury R. Holman

A Clinical Screening Tool Identifies Autoimmune Diabetes in Adults: Response to Fourlanos et al.

• Robert H. Knopp

Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN): Response to Gazi and Mikhailidis

• Irene F. Gazi and
• Dimitri P. Mikhailidis

Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN): Response to Knopp

• Graham P. Leese and
• Andrew D. Morris

Prediction of Diabetic Foot Ulcer Occurrence Using Commonly Available Clinical Information: Response to Boyko et al.

• Kingston H. Tseng

Standards of Medical Care in Diabetes–2006: Response to the American Diabetes Association

• Edward J. Boyko,
• Jessie H. Ahroni,
• and Karin M. Nelson

Prediction of Diabetic Foot Ulcer Occurrence Using Commonly Available Clinical Information: Response to Leese and Morris

• Vivian Fonseca and
• Nathaniel G. Clark

Standards of Medical Care in Diabetes–2006: Response to Tseng

• Scott M. Grundy

Does the Metabolic Syndrome Exist?: Response to Davidson

• Mayer B. Davidson

Does the Metabolic Syndrome Exist: Response to Grundy

• Richard Kahn

The Metabolic Syndrome (Emperor) Wears No Clothes: Response to Oda

• Eiji Oda

The Metabolic Syndrome (Emperor) Wears No Clothes: Response to Kahn

• Miquel Porta

A Strong Dose-Response Relation Between Serum Concentrations of Persistent Organic Pollutants and Diabetes: Results From the National Health and Nutrition Examination Survey 1999–2002: Response to Lee et al.

• Duk-Hee Lee and
• David R. Jacobs, Jr.

A Strong Dose-Response Relation Between Serum Concentrations of Persistent Organic Pollutants and Diabetes: Results From the National Health and Nutrition Examination Survey 1999–2002: Response to Porta

Errata

Errata